Skip to main content

Table 5 Double-blind placebo-controlled food challenge (DBPCFC) and initial food escalation (IFE) schedule

From: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy

Protein amount in mg (1:1:1) 0.3 1 3 10 30 100 300a 600 1050 1500
Observation time (min) 30 30 30 30 30 30 30b 30 30 120
  1. aLast step for DBPCFC
  2. bobserved for 2 h during DBPCFC